Porton Pharma Solutions Ltd. (SHE:300363)

China flag China · Delayed Price · Currency is CNY
24.72
+0.12 (0.49%)
Oct 21, 2025, 2:47 PM CST
0.49%
Market Cap13.34B
Revenue (ttm)3.28B
Net Income (ttm)-90.66M
Shares Out542.18M
EPS (ttm)-0.17
PE Ration/a
Forward PE184.50
Dividendn/a
Ex-Dividend Daten/a
Volume12,619,511
Average Volume22,035,282
Open25.03
Previous Close24.60
Day's Range24.05 - 25.03
52-Week Range12.31 - 29.50
Beta0.61
RSI48.28
Earnings DateOct 24, 2025

About Porton Pharma Solutions

Porton Pharma Solutions Ltd. provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial. It has a strategic collaboration with Aojin Life Sciences to advance XDC conjugate drugs; and strategic partnership with Porton Pharma Solutions and Dragon Sail Pharmaceutical to build a new ecosystem for ADC drug development, production, and supply chain. The company operates in China and internationally. The company was formerly known as Porton Fine Ch... [Read more]

Sector Healthcare
Founded 2005
Employees 4,214
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300363
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.